The Patent Finder

Neopharm, Inc.

Also on record
Records under this name other than the patents Neopharm, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 18 patents it holds.

Back to Neopharm, Inc.

PatentTitleStatus Expires Confidence
US 7,442,520Gene BRCC-3 and Diagnostic and Therapeutic Uses Thereof
Formerly held
Term ended
Term ended Dec 18, 2022 · Medium confidence
Term endedTerm ended Dec 18, 2022Medium confidence
US 8,809,541Heterocyclic compound, and composition for treating inflammatory diseases using same
Lapsed on the fee record
Ended Aug 19, 2022 · From the USPTO record
Lapsed on the fee recordEnded Aug 19, 2022From the USPTO record
US 7,542,511Wireless RF link for uncompressed transmission of HDTV signals
Lapsed on the fee record
Ended Jun 2, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jun 2, 2021From the USPTO record
US 7,253,272Gene BRCC-2 and Diagnostic and Therapeutic Uses Thereof
Formerly held
Term ended
Term ended May 14, 2021 · Medium confidence
Term endedTerm ended May 14, 2021Medium confidence
US 8,298,573Stable Sterile Filterable Liposomal Encapsulated Taxane and Other Antineoplastic Drugs
Formerly held
Lapsed on the fee record
Ended Oct 30, 2020 · Medium confidence
Lapsed on the fee recordEnded Oct 30, 2020Medium confidence
US 6,461,637Method of administering liposomal encapsulated taxane
Term ended
Ended no later than Sep 1, 2020 · From the USPTO record
Term endedEnded no later than Sep 1, 2020From the USPTO record
US 7,314,637Method of administering liposomal encapsulated taxane
Term ended
Ended no later than Jun 29, 2019 · From the USPTO record
Term endedEnded no later than Jun 29, 2019From the USPTO record
US 6,221,371Pseudoceramides, and dermatologic external preparations containing the same
Term ended
Term ended May 10, 2019 · From the USPTO record
Term endedTerm ended May 10, 2019From the USPTO record
US 6,146,659Method of administering liposomal encapsulated taxane
Term ended
Term ended Jul 1, 2018 · From the USPTO record
Term endedTerm ended Jul 1, 2018From the USPTO record
US 7,462,739Ceramide derivatives, method for preparing the same, and therapeutic agent for treating atopic dermatitis comprising the ceramide derivatives
Lapsed on the fee record
Ended Dec 9, 2016 · From the USPTO record
Lapsed on the fee recordEnded Dec 9, 2016From the USPTO record
10 of 16 patents shown.
Pro members see all 16.
Pro members: see all 16 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited